Figure 1. Absolute number and relative proportion of disease indications. (A) Allogeneic transplants, (B) Autologous transplants.

AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; CML, chronic myeloid leukemia; MDS/MPN, myelodysplastic/myeloproliferative neoplasm; MPN, myeloproliferative neoplasm; MPD, myeloproliferative disorder; MPS, myeloproliferative syndrome; CLL, chronic lymphatic leukemia; PCD, plasma cell disorders; HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; SAA, severe aplastic anemia; PID, primary immune deficiencies; IDM, inherited disorders of metabolism; AID, autoimmune diseases